TABLE 1.
P. aeruginosa strains used in this study
| Isolate | Phenotype | Source or reference |
|---|---|---|
| Laboratory strains | ||
| PAO1-V | Chloramphenicol sensitive | M. Vasil, Denver, Colo. |
| PAO1-I | Chloramphenicol resistant | B. Iglewski, Rochester, N.Y. |
| PA103 | lasR mutant; exoU+; serogroup O11 | 14 |
| PAK | Serogroup O6 | S. Lory, Seattle, Wash. |
| PAC557 | Complete-core LPS; no O side chains | 29 |
| PAO1 algC::tet | algC mutant; incomplete-core LPS | 8 |
| Clinical isolates | ||
| 149 | CF patient | Children's Hospital, Boston, Mass. |
| 324 | CF patient | Children's Hospital, Boston, Mass. |
| 383 | CF patient | Children's Hospital, Boston, Mass. |
| 6294 | Ulcerative keratitis patient | Bascom-Palmer Eye Institute, Miami, Fla. |
| 6206 | Ulcerative keratitis patient | Bascom-Palmer Eye Institute, Miami, Fla. |
| 6487 | Ulcerative keratitis patient | Bascom-Palmer Eye Institute, Miami, Fla. |
| 2BI | Pneumonia patient | Beth Israel Hospital, Boston, Mass. |
| 10CH | Pneumonia patient | Children's Hospital, Boston, Mass. |